KERALA AYURVEDA
|
KERALA AYURVEDA Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -1.30 | -0.51 | 2.24 | -4.59 | 3.69 |
| CEPS(Rs) | 0.40 | 0.64 | 3.41 | -3.38 | 4.92 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 24.13 | 2.57 | 2.93 | 0.37 | 4.65 |
| Tax Rate(%) | 167.89 | 23.43 | 14.66 | 28.12 | 10.67 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 6.26 | 2.81 | 11.86 | 1.35 | 9.58 |
| EBIT Margin(%) | 5.50 | 4.96 | 11.79 | -0.52 | 8.12 |
| Pre Tax Margin(%) | 1.18 | -0.60 | 3.49 | -10.86 | 5.91 |
| PAT Margin (%) | -0.80 | -0.46 | 2.98 | -7.80 | 5.28 |
| Cash Profit Margin (%) | 0.45 | 0.73 | 4.47 | -5.74 | 6.77 |
| Performance Ratios | |||||
| ROA(%) | -0.67 | -0.38 | 2.14 | -4.47 | 4.15 |
| ROE(%) | -5.44 | -14.76 | 137.66 | -183.03 | 93.90 |
| ROCE(%) | 6.75 | 6.18 | 12.62 | -0.45 | 9.27 |
| Asset Turnover(x) | 0.84 | 0.83 | 0.72 | 0.57 | 0.79 |
| Sales/Fixed Asset(x) | 1.53 | 1.36 | 1.32 | 1.41 | 1.79 |
| Working Capital/Sales(x) | 5.48 | -5.36 | -3.46 | 35.84 | 32.33 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.66 | 0.73 | 0.76 | 0.71 | 0.56 |
| Receivable days | 48.66 | 51.38 | 53.75 | 61.85 | 41.85 |
| Inventory Days | 47.37 | 47.80 | 52.19 | 70.07 | 58.03 |
| Payable days | 155.66 | 169.01 | 183.24 | 186.13 | 164.33 |
| Valuation Parameters | |||||
| PER(x) | - | - | 34.93 | - | 9.91 |
| PCE(x) | 654.48 | 129.56 | 22.94 | -15.20 | 7.43 |
| Price/Book(x) | 10.83 | 32.49 | 26.68 | 140.57 | 7.87 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 3.35 | 1.69 | 1.86 | 1.81 | 1.26 |
| EV/Core EBITDA(x) | 49.67 | 54.32 | 15.14 | 117.92 | 13.07 |
| EV/EBIT(x) | 60.92 | 34.07 | 15.79 | -345.33 | 15.47 |
| EV/CE(x) | 3.66 | 2.05 | 1.36 | 0.99 | 0.94 |
| M Cap / Sales | 2.91 | 0.94 | 1.03 | 0.87 | 0.50 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 15.46 | 16.25 | 29.45 | -19.15 | 23.46 |
| Core EBITDA Growth(%) | 150.12 | -70.56 | 936.66 | -87.09 | 37.28 |
| EBIT Growth(%) | 27.92 | -51.06 | 3,011.19 | -105.22 | 9.92 |
| PAT Growth(%) | -101.52 | -117.89 | 149.42 | -219.50 | 60.63 |
| EPS Growth(%) | -156.74 | -122.61 | 148.76 | -224.28 | 59.43 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 2.40 | 27.42 | 22.60 | 198.89 | 13.08 |
| Current Ratio(x) | 1.49 | 0.67 | 0.61 | 1.04 | 1.08 |
| Quick Ratio(x) | 1.10 | 0.43 | 0.42 | 0.78 | 0.66 |
| Interest Cover(x) | 1.27 | 0.89 | 1.42 | -0.05 | 3.67 |
| Total Debt/Mcap(x) | 0.22 | 0.84 | 0.85 | 1.41 | 1.66 |
Compare Financial Ratios of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹371.8 Cr | 14.7% | 16.5% | 36.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
| CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | 14.7% |
16.5% |
36.1% |
| SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses
